IM Cannabis (IMCC) Treasury Shares (2021 - 2022)
IM Cannabis (IMCC) recorded quarterly Treasury Shares of -$486223.9 in Q4 2022, up 3.92% quarter-over-quarter from -$506052.5 in Q3 2022, and up 7.14% on a YoY basis from -$453827.0 in Q4 2021.
IM Cannabis (IMCC) Treasury Shares (2021 - 2022) Analysis & Trends
IM Cannabis' Treasury Shares history runs 2 years deep, the most recent figure standing at -$486223.9 for Q4 2022.
- In Q4 2022, Treasury Shares rose 7.14% year-over-year to -$486223.9; the TTM figure through Dec 2022 stood at -$486223.9 (up 7.14% YoY), while the FY2022 annual figure was -$507649.6, up 3.61% from the prior year.
- Treasury Shares was -$486223.9 for Q4 2022 at IM Cannabis, up from -$506052.5 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of -$486223.9 in Q4 2022 to a low of -$523601.8 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 107.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 4.80 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.42 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 17.13 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 7.24 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 19.58 Mn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -486,223.94 |
| Dec 31, 2022 | -486,223.94 |
| Sep 30, 2022 | -506,052.52 |
| Sep 30, 2022 | -506,052.52 |
| Jun 30, 2022 | -517,664.83 |
| Jun 30, 2022 | -517,664.83 |
| Mar 31, 2022 | -521,053.77 |
| Mar 31, 2022 | -521,053.77 |
| Dec 31, 2021 | -523,601.81 |
| Dec 31, 2021 | -523,601.81 |